If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Cell Aging Medicine & Life Sciences
Inflammatory Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
X-Linked Inhibitor of Apoptosis Protein Medicine & Life Sciences
Oncogenes Medicine & Life Sciences
Tumors Chemical Compounds
Nucleotides Medicine & Life Sciences
Apoptosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2019

Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer

Aird, K.

National Institutes of Health


Project: Research projectCareer Transition Award, Research Transition Award

Ovarian Neoplasms
Neoplastic Stem Cells

Research Output 2004 2018

Deoxyribonucleotide triphosphate metabolism in cancer and metabolic disease

Buj, R. & Aird, K. M., Apr 18 2018, In : Frontiers in Endocrinology. 9, APR, 177

Research output: Contribution to journalShort survey

Metabolic Diseases
Metabolic Networks and Pathways
16 Citations

ARID1A-mutated ovarian cancers depend on HDAC6 activity

Bitler, B. G., Wu, S., Park, P. H., Hai, Y., Aird, K. M., Wang, Y., Zhai, Y., Kossenkov, A. V., Vara-Ailor, A., Rauscher, F. J., Zou, W., Speicher, D. W., Huntsman, D. G., Conejo-Garcia, J. R., Cho, K. R., Christianson, D. W. & Zhang, R., Aug 1 2017, In : Nature Cell Biology. 19, 8, p. 962-973 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Chromatin Assembly and Disassembly
2 Citations

Ataxia-telangiectasia mutated modulation of carbon metabolism in cancer

Dahl, E. S. & Aird, K. M. Nov 29 2017 In : Frontiers in Oncology. 7, NOV, 291

Research output: Contribution to journalShort survey

Ataxia Telangiectasia
Ataxia Telangiectasia Mutated Proteins

Ovarian cancer: How can resistance to chemotherapy be tackled?

Karakashev, S. & Aird, K. M. Dec 1 2017 In : Future Oncology. 13, 30, p. 2737-2739 3 p.

Research output: Contribution to journalReview article

Ovarian Neoplasms
Drug Therapy
3 Citations

Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations

Bitler, B. G., Aird, K. M. & Zhang, R., Jan 2 2016, In : Molecular and Cellular Oncology. 3, 1, e1032476

Research output: Contribution to journalArticle

Mutation Rate